These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 8106965

  • 1. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
    Balfour HH, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B, Safrin S.
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
    Marks GL, Nolan PE, Erlich KS, Ellis MN.
    Rev Infect Dis; 1989 Mar; 11(3):474-6. PubMed ID: 2546244
    [Abstract] [Full Text] [Related]

  • 4. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C, Bianchi A.
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [Abstract] [Full Text] [Related]

  • 5. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landry B, Mills J.
    N Engl J Med; 1991 Aug 22; 325(8):551-5. PubMed ID: 1649971
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF, Cornelissen JJ, Smit J, Lepoutre J, de Gast GC, Dekker AW, Rozenberg-Arska M.
    Bone Marrow Transplant; 1993 Feb 22; 11(2):177-9. PubMed ID: 8382096
    [Abstract] [Full Text] [Related]

  • 11. Polish consensus guidelines on the use of acyclovir in the treatment and prevention of VZV and HSV infections.
    Szenborn L, Kraszewska-Głomba B, Jackowska T, Duszczyk E, Majda-Stanisławska E, Marczyńska M, Ołdak E, Pawłowska M, Służewski W, Wysocki J, Stryczyńska-Kazubska J, Kuchar E.
    J Infect Chemother; 2016 Feb 22; 22(2):65-71. PubMed ID: 26643900
    [Abstract] [Full Text] [Related]

  • 12. [Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS].
    Ramos C, Lajusticia J.
    Enferm Infecc Microbiol Clin; 2004 Apr 22; 22(4):253-4. PubMed ID: 15056447
    [No Abstract] [Full Text] [Related]

  • 13. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
    Jansen CL, Maris-Tegeler WG, Wertheim-van Dillen PM, Frissen PH, Weiland HT, van der Noordaa J.
    Ned Tijdschr Geneeskd; 1992 Feb 08; 136(6):280-4. PubMed ID: 1311058
    [Abstract] [Full Text] [Related]

  • 14. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection.
    Safrin S, Berger TG, Gilson I, Wolfe PR, Wofsy CB, Mills J, Biron KK.
    Ann Intern Med; 1991 Jul 01; 115(1):19-21. PubMed ID: 1646585
    [Abstract] [Full Text] [Related]

  • 15. Chronic ulcerating acyclovir-resistant varicella zoster lesions in an AIDS patient.
    Bernhard P, Obel N.
    Scand J Infect Dis; 1995 Jul 01; 27(6):623-5. PubMed ID: 8685644
    [Abstract] [Full Text] [Related]

  • 16. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    Tan HH, Goh CL.
    Am J Clin Dermatol; 2006 Jul 01; 7(1):13-29. PubMed ID: 16489840
    [Abstract] [Full Text] [Related]

  • 17. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
    Med Lett Drugs Ther; 2018 Sep 24; 60(1556):153-157. PubMed ID: 30383727
    [No Abstract] [Full Text] [Related]

  • 18. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
    Birch CJ, Tyssen DP, Tachedjian G, Doherty R, Hayes K, Mijch A, Lucas CR.
    J Infect Dis; 1992 Jul 24; 166(1):108-12. PubMed ID: 1318909
    [Abstract] [Full Text] [Related]

  • 19. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Venard V, Dauendorffer JN, Carret AS, Corsaro D, Edert D, Bordigoni P, Le Faou A.
    Pathol Biol (Paris); 2001 Sep 24; 49(7):553-8. PubMed ID: 11642018
    [Abstract] [Full Text] [Related]

  • 20. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Arnulf B, Chebbi F, Lefrere F, Ait Arkoub Z, Varet B, Fillet AM.
    Bone Marrow Transplant; 2001 Oct 24; 28(8):799-801. PubMed ID: 11781635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.